This is a preview of subscription content, log in via an institution to check access.
Reference
Matuoka JY, et al. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. European Journal of Health Economics : 31 Oct 2018. Available from: URL: https://doi.org/10.1007/s10198-018-1011-1
Rights and permissions
About this article
Cite this article
Denosumab not cost effective for treatment of bone metastases. PharmacoEcon Outcomes News 816, 9 (2018). https://doi.org/10.1007/s40274-018-5429-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5429-6